Skip to main content
. 2021 Jan 15;37(1):7–17. doi: 10.5146/tjpath.2020.01503

Table 1.

Characteristics of the ‘203 primary resection lung adenocarcinoma specimens’ and correlations between the patients harboring EML4-ALK mutation.

 

Total (%)

EML4-ALK Rearrangement

P

Positive (%)

Negative (%)

Age

(mean±SD, years)

 

63±8.84

 

62.11±8.89

 

62.4±12.2

0.500

Gender

Male

Female

 

150 (73.9)

53 (26.1)

 

3 (2)

2 (3.8)

 

147 (98)

51 (96.2)

0.608

Size

mean±SD (cm)

 

3.7±2.5

 

5.54±3.34

 

3.61±2.02

0.037

Pathological T-stage

T1A

T1B

T1C

T2A

T2B

T3

T4

 

7 (3.4)

23 (11.3)

32 (15.8)

75 (37)

23 (11.3)

25 (12.3)

18 (8.9)

 

 

 

 

 

Pathological N-stage

Nx

N0

N1

N2

 

37 (18.2)

108 (53.2)

37 (18.2)

21 (3.7)

 

1 (0.8)

2 (1.9)

11 (0.8)

1 (4.8)

 

36 (97.2)

106 (98.1)

36 (97.2)

20 (95.2)

0.611

Visseral pleural invasion

Positive

Negative

 

111 (54.7)

92 (45.3)

 

3 (2.8)

2 (2.2)

 

109 (97.2)

90 (97.8)

0.308

Smoking history

Never

Ever

 

43 (21.2)

160 (78.8)

 

3 (7)

2 (1.3)

 

40 (93)

158 (98.7)

0.064

Stage

IA

IB

IIA

IIB

IIIA

IIIB

IV

Unknown

 

47 (23.1)

52 (25.6)

23 (11.3)

14 (6.8)

22 (10.8)

3 (1.5)

24 (11.8)

18 (9.1)

 

Stage I

2 (2.1)

Stage II, III, IV

3 (2.9)

 

Stage I

97 (97.9)

Stage II, III, IV

101 (97.1)

0.489

Dominant pattern

Acinar

Papillary

Lepidic

Micropapillary

Solid

Fetal

Mucinous

Enteric

Adenosquamous

 

118 (58.1)

29 (14.3)

6 (3.5)

4 (2)

30 (14.8)

1 (0.2)

12 (5.9)

1 (0.2)

2 (1)

 

Acinar

1 (2.4)

Solid

4 (13.4)

 

Acinar

117 (97.6)

Solid

26 (86.6)

0.008